Riskpilot← Back to searchSign inGet full accessNovelia Vård AB
ABActiveOrg 5591561724Hästholmsvägen 28Other social work activities without accommodation n.e.c. · NACE 8899Est. 20181-4 employees
Revenue 2024
SEK 415K
EBITDA margin
-38.6%
-15900% vs 2023
Equity ratio
9.5%
Financial strength
Net profit 2024
SEK 0
+100% vs 2023
| Revenue | SEK 415K | — |
| EBITDA | SEK -160K | -15900% |
| Net profit | SEK 0 | +100% |
| Total assets | SEK 526K | +952% |
| Equity | SEK 50K | +0% |
| Employees | — | — |
Legal name
Novelia Vård AB
Org number
5591561724
Legal form
Aktiebolag
NACE code
8899 · Other social work activities without accommodation n.e.c.
Founded
18 april 2018
Share capital
SEK 50 000
Employees
1-4
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva utredning, behandling, vård, utbildning samt forskning inom sjukvård och därmed förenlig verksamhet. Bolaget skall även bedriva sociala tjänster, hem för vård eller boende (HVB), samt äga och förvalta värdepapper och fastigheter samt därmed förenliga verksamheter.
Address
Hästholmsvägen 28
Email
maria@novelia.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 256 | 170 | 0 | 0 | 415 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 203 | 168 | −2 | −1 | −160 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 203 | 168 | −2 | −1 | −160 |
| Net financials | −3 | −1 | −1 | −1 | 1 |
| Profit before tax | 1 | 168 | −2 | −2 | 0 |
| Tax | −1 | −36 | −0 | −0 | −0 |
| Net profit | 0 | 132 | −2 | −2 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 472 | 354 | 352 | 50 | 526 |
| Equity | 222 | 354 | 352 | 50 | 50 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 250 | 0 | 0 | 0 | 476 |
| Total debt | 250 | — | — | — | 476 |
EBITDA margin
-38.6%
This company
15.8%
Market median
-344% vs market
20202024
Equity ratio
9.5%
This company
38.2%
Market median
-75% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
20202024
Debt / equity
9.52×
This company
0.62×
Market median
-1435% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
KM Chief Executive Officer | Chief Executive Officer | 2024 |
JH Auditor Substitute | Auditor Substitute | 2024 |
EC Audit | Audit | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2026 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (5) | ||
| Board of Directors | 2024 – 2026 | |
| Board of Directors | 2020 – 2024 | |
| Chairman | 2020 – 2024 | |
| Deputy Board Member | 2020 – 2024 | |
| Board of Directors | 2020 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Novelia Vård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Maria Baker | Chief Executive Officer | 0 companies |
| Josefin Hillewi Mikaela Riberth | Auditor Substitute | 0 companies |
| Eva Cajsa Marcelius | Audit | 0 companies |
| Julia Tonie Erica Jardéus | Board of Directors | 0 companies |
| Jan Peter Raimisto | Board of Directors | 0 companies |
| Franz Eskil Agefjäll Baumann | Chairman | 0 companies |
| Elin Marie Lina Creutz | Board of Directors | 0 companies |
| Erik Johan Christer Lundqvist | Deputy Board Member | 0 companies |
| Ursula Elisabeth Bley Arvidsson | Chairman | 0 companies |
| Anders Rickard Ljunggren | Board of Directors | 0 companies |
| Mats Johan Eiert Saxelin | Board of Directors | 0 companies |